Hiroaki Ihara
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 10
- Lung Cancer Treatments and Mutations 2
- Renal and Vascular Pathologies 1
-
- Mycobacterium research and diagnosis 5
- Co-authors
- Kazuhisa Takahashi (23 shared papers)Motoyasu Kato (13 shared papers)Fumiyuki Takahashi (9 shared papers)Shinichi Sasaki (8 shared papers)Kana Kurokawa (6 shared papers)Yusuke Ochi (12 shared papers)Tomoko Yamada (4 shared papers)Takahiro Nakamura (2 shared papers)
In The Last Decade
Hiroaki Ihara
27 papers receiving 327 citations
Peers
Comparison fields: 5 of 59
- Pulmonary and Respiratory Medicine 186
- Oncology 54
- Cancer Research 20
- Epidemiology 43
- Microbiology 1
Countries citing papers authored by Hiroaki Ihara
This map shows the geographic impact of Hiroaki Ihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ihara more than expected).
Fields of papers citing papers by Hiroaki Ihara
This network shows the impact of papers produced by Hiroaki Ihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ihara. The network helps show where Hiroaki Ihara may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroaki Ihara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 62 | |
| 2 | 2019 | 42 | |
| 3 | 2018 | 34 | |
| 4 | 2019 | 29 | |
| 5 | 2018 | 21 | |
| 6 | 2020 | 21 | |
| 7 | 2021 | 19 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 11 | |
| 12 | 2017 | 11 | |
| 13 | 2016 | 9 | |
| 14 | 2013 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2014 | 2 | |
| 20 | 2019 | 2 |
About Hiroaki Ihara
Hiroaki Ihara is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Oncology, Infectious Diseases and Organic Chemistry, having authored 33 papers that have together received 333 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Mycobacterium research and diagnosis (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Tuberculosis Research and Epidemiology (3 papers), Quinazolinone synthesis and applications (2 papers), Lung Cancer Treatments and Mutations (2 papers), Renal and Vascular Pathologies (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (186 citations), Oncology (54 citations), Cancer Research (20 citations), Epidemiology (43 citations) and Microbiology (1 citation). Hiroaki Ihara has collaborated with scholars based in Japan and China. Frequent co-authors include Kazuhisa Takahashi, Motoyasu Kato, Fumiyuki Takahashi, Shinichi Sasaki, Kana Kurokawa, Yusuke Ochi, Tomoko Yamada, Takahiro Nakamura, Ken Tajima and Chikahiro Miyake. Their work appears in journals such as Scientific Reports, Drug Design Development and Therapy, Stem Cell Research & Therapy, Frontiers in Plant Science and Respiration.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.